MX2021010289A - Human milk oligosaccharides for use in enhancing executive function. - Google Patents

Human milk oligosaccharides for use in enhancing executive function.

Info

Publication number
MX2021010289A
MX2021010289A MX2021010289A MX2021010289A MX2021010289A MX 2021010289 A MX2021010289 A MX 2021010289A MX 2021010289 A MX2021010289 A MX 2021010289A MX 2021010289 A MX2021010289 A MX 2021010289A MX 2021010289 A MX2021010289 A MX 2021010289A
Authority
MX
Mexico
Prior art keywords
human milk
infant
executive function
milk oligosaccharides
hmo
Prior art date
Application number
MX2021010289A
Other languages
Spanish (es)
Inventor
Bruce Mcconnell
Jonas Hauser
Louise Kristine Vigsnæs
Nora Schneider
Original Assignee
Glycom As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycom As filed Critical Glycom As
Publication of MX2021010289A publication Critical patent/MX2021010289A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/28—Oligosaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pediatric Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Dairy Products (AREA)

Abstract

Use of a human milk oligosaccharide (HMO), or a nutritional composition comprising a human milk oligosaccharide, to enhance executive function in a non-infant, to prevent and/or reduce the risk of sub- optimal executive function in a non-infant, to manage sub-optimal executive functioning in a non-infant, and/or to improve myelination to mature the pre -frontal cortex region of the brain in a non-infant, as well as synthetic compositions of HMOs and packs comprising at least 14 individual daily doses of an effective amount of at least one HMO for such a use.
MX2021010289A 2019-03-05 2020-03-05 Human milk oligosaccharides for use in enhancing executive function. MX2021010289A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19160876 2019-03-05
EP19161023 2019-03-06
EP19214414 2019-12-09
DKPA201901446 2019-12-09
PCT/IB2020/051904 WO2020178774A1 (en) 2019-03-05 2020-03-05 Human milk oligosaccharides for use in enhancing executive function

Publications (1)

Publication Number Publication Date
MX2021010289A true MX2021010289A (en) 2022-02-10

Family

ID=72338226

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021010289A MX2021010289A (en) 2019-03-05 2020-03-05 Human milk oligosaccharides for use in enhancing executive function.

Country Status (9)

Country Link
US (1) US20220160013A1 (en)
EP (1) EP3934657A4 (en)
JP (1) JP2022523560A (en)
KR (1) KR20210136059A (en)
CN (1) CN113825516A (en)
AU (1) AU2020231116A1 (en)
BR (1) BR112021016924A2 (en)
MX (1) MX2021010289A (en)
WO (1) WO2020178774A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023553548A (en) * 2020-12-04 2023-12-22 グリコム・アクティーゼルスカブ Human breast milk oligosaccharides for use in supporting maturation or improvement of sleep patterns
GB202114190D0 (en) * 2021-10-04 2021-11-17 Mjn Us Holdings Llc Compositions for preventing and/or treating demyelination
KR102527378B1 (en) * 2022-04-28 2023-05-02 (주)에이피테크놀로지 Composition for improvement, prevention and treatment of diseases caused by a decrease in dopamine with 2'-fucosyllactose

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103763940B (en) * 2010-12-31 2015-10-14 雅培制药有限公司 Promote the probio of effective microorganisms growth and the conjunction benefit element combination of human milk oligosaccharides
EP3704957A1 (en) * 2012-09-14 2020-09-09 Abbott Laboratories Methods for increasing brain functionality using 2-fucosyl-lactose
EP2888950A1 (en) * 2013-12-24 2015-07-01 Abbott Laboratories Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment
WO2016145628A1 (en) * 2015-03-18 2016-09-22 Nestec S.A. Composition comprising siallyllactose for use in enhancing learning skills and memory function
CN108289492A (en) * 2015-12-15 2018-07-17 雀巢产品技术援助有限公司 The mixture of HMO
EP3845233A1 (en) * 2016-01-13 2021-07-07 Benebiosis Co., Ltd. Composition for increasing expression of pgc-1a
CN109715169A (en) * 2016-07-28 2019-05-03 方塔拉合作集团有限公司 Dairy products and technique
US20200108084A1 (en) * 2017-05-24 2020-04-09 Societe Des Produits Nestle S.A. Composition comprising oligofructose (of) for use in the improvement of short term memory and other cognitive benefits
EP3629769A1 (en) * 2017-05-24 2020-04-08 Société des Produits Nestlé S.A. Composition comprising human milk oligosaccharides (hmo) for use in the improvement of short term memory and other cognitive benefits
RU2019141949A (en) * 2017-05-24 2021-06-17 Сосьете Де Продюи Нестле С.А. NUTRIENT COMPOSITION FOR USE IN INCREASING ATTENTION AND / OR REDUCING IMPULSE

Also Published As

Publication number Publication date
EP3934657A1 (en) 2022-01-12
US20220160013A1 (en) 2022-05-26
CN113825516A (en) 2021-12-21
KR20210136059A (en) 2021-11-16
EP3934657A4 (en) 2023-01-04
BR112021016924A2 (en) 2021-11-03
WO2020178774A1 (en) 2020-09-10
JP2022523560A (en) 2022-04-25
AU2020231116A1 (en) 2021-09-23

Similar Documents

Publication Publication Date Title
MX2021010289A (en) Human milk oligosaccharides for use in enhancing executive function.
PH12016500762A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
PH12015501309A1 (en) Human milk oligosaccharides to ameliorate symptoms of stress
MD3788045T2 (en) RIP1 inhibitory compounds and methods for making and using the same
TN2012000270A1 (en) Methods and low dose regimens for treating red blood cell disorders
PH12019500799A1 (en) Personalized pediatric nutrition products comprising human milk oligosaccharides
PH12018501297A1 (en) Human milk oligosaccharides against later in life excessive fat mass accumulation and related health disorders
PH12015500738A1 (en) Shelf-stable, clear liquid nutritional compositions comprising epigallocatechin gallate (egcg) and methods for preparing the same
MX2021012894A (en) Cyclic phosphate compounds.
WO2016190682A3 (en) Composition for preventing and treating muscle diseases or improving muscular function, containing morusin, kuwanon g, or mori cortex radicis
MX2023006261A (en) Compositions comprising human milk oligosaccharides for use in a subject to support night sleep duration.
WO2015048503A3 (en) N-arylmethyl sulfonamide negative modulators of nr2a
CN101112463A (en) Composition of the compatibility of blueberry fruit and vine seed with svitamin C and vitamin E
MX2022006411A (en) Compositions comprising human milk oligosaccharides for use in a subject to support language development.
CN102204982A (en) Composition for comprehensively improving physiological function of genital system and preventing pathogen infection
JOP20190275A1 (en) Methods and compositions for treating congenital diarrhea disorder
SA521431033B1 (en) Super-Oxide Dismutase Soluble Fiber Compositions
NZ626573A (en) Glutamine enriched nutritional composition for preterm infants
CN106804729A (en) A kind of Quinquagenarian formula milk powder for improving intelligence
Papageorgiou et al. The Effects of Short-Term Low Energy Availability on Bone Turnover in Men: 1537 May 28, 1: 30 PM-1: 45 PM
MX2021010210A (en) A nutritional composition for use to enhance executive function.
CN107641249A (en) A kind of fat reducing machine plastic casing
MX2021005669A (en) Methods for enhancing metabolic health in an animal.
PH12014502014B1 (en) Animal feed composition containing encapsulated glucono delta-lactone
MY197162A (en) Use of a composition for suppressing metabolic syndrome and osteoporosis